Keywords: biogen, profits, rocket, fourth, quarter, usa-based, posted
Biogen profits rocket in fourth quarter
Article | 03 February 2003
USA-based Biogen has posted net income of $81 million, or $0.53 pershare, for the fourth quarter ended December 31, 2002, compared with $58.9 million, or $0.39 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
